CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease

This publication has 53 references indexed in Scilit:

• Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients
  Blood, 2003
• CD4+CD25+ Immunoregulatory T Cells
  Journal of Experimental Medicine, 2002
• Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting Cells
  Science, 1999
• CD4 T cell traffic control:in vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles
  European Journal of Immunology, 1999
• Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation
  Bone Marrow Transplantation, 1999
• OX-40: life beyond the effector T cell stage
  Seminars in Immunology, 1998
• The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells.
  Journal of Experimental Medicine, 1996
• The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response.
  Journal of Experimental Medicine, 1996
• Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease.
  Journal of Experimental Medicine, 1996
• Identification of a Graft Versus Host Disease-Associated Human Minor Histocompatibility Antigen
  Science, 1995